World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—
More about Pharmadax
- Acquisitions and changes
- No longer listed: it is not in the Taiwan Stock Exchange's register of listed companies or the Taipei Exchange's registers of OTC and emerging-board companies (checked 14 November 2026).
Market cap history
World rank over time
▼ down 3,432 places since 2020
Rank in Taiwan: #1,026 (Jan 2020) · #1,187 (Jan 2022)
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Pharmadax🇹🇼 | $98 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
Sources and freshness
- Market cap:
- Jan 7, 2022 (last known)
- Profile updated:
- Nov 15, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Pharmadax? Verify and update this profile — free
Show Pharmadax's ranking on your website Get the badge
The badge updates itself as the ranking changes.